CytRx Corp.

CytRx Corp.
Stock Exchange NASDAQ Stock Market
EPS
$0.42
Market Cap
$12.36 M
Shares Outstanding
33.64 M
Public Float
30.78 M

Profile

Address
11726 San Vicente Boulevard
Los Angeles California 90049
United States
Employees -
Website http://www.cytrx.com
Updated 07/08/2019
CytRx Corp. operates as a biopharmaceutical research and development company specializing in oncology. It focuses on discovering, developing, and commercializing new therapeutics to treat patients with cancer; including aldoxorubicin, a modified version of the widely-used chemotherapeutic agent, doxorubicin. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.

Financials

View All
Created with Highcharts 5.0.14CytRx Corp.Net Income. Fiscal year is January-December. All values USD Thousands.47 48547 48530 11830 11858 58758 58750 77150 77134 98634 9869 0799 079201320142015201620172018010k20k30k40k50k60k70k
Created with Highcharts 5.0.14CytRx Corp.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.300300100100100100200200100100250250201320142015201620172018050100150200250300350

Steven A. Kriegsman
Chairman & Chief Executive Officer
Joel Caldwell
Director